chrisvoncsefalvay/vaers-outcomes huggingface dataset:
We had all 4 of the shots and the immunoglobulin for post exposure; This case was reported by a consumer via other manufacturer and described the occurrence of incomplete course of vaccination in a 27-year-old female patient who received Rabies NVS (RabAvert) for prophylaxis.   Previously administered products included RabAvert (1st dose received with immunoglobulins on 22nd November 2016), RabAvert (2nd dose received on 25th November 2016), RabAvert (3rd dose received on 29th November 2016) and RabAvert (4th dose received on 6th December 2016).   On an unknown date, the patient received the 5th dose of RabAvert. On an unknown date, unknown after receiving RabAvert, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows: The age at vaccination was not applicable for this report. The patient's mother reported that they had bat in the house and the patient received 4 shots with immunoglobulins. All 4 doses received in 2016 and the patient had not received 5th dose which led to incomplete course of vaccination. This was medication error without harm. The reporter consented for follow up. This is 1 of 3 cases reported.   Following internal review it was determined that initial reciept date was 12th August 2020, which is earlier than initially reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR163493: US-GLAXOSMITHKLINE-US2020AMR163473:
Pt with redness, swelling to left deltoid after PROQUAD injection. Injection adminsitered 2 days ago. First noted 1 day ago by mother. Seems to worsen overnight. 5" w x 4" L.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was reported.  The time of Vaccination was 02:59 PM.
The evening of my shot my arm felt sore. The next morning it hurt to raise it above my chest. I also had pain in my arm pit. I then had body aches and body chills and a low grade fever. Ibuprofen took care of most of that. I did continue having the armpit pain and I developed a rash where I received my shot and I still have both of those symptoms although they're getting better.
This is a spontaneous report from a contactable physician, reporting for himself. A male patient of an unspecified age and race/ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced redness at injection site (shoulder) and abscess in the throat. The events were non-serious. The outcome of the events was unknown. No follow up attempts are possible. No further information is expected.
Within a few minutes of taking the vaccine, my lower lip began swelling. I was moved to the emergency department of Hospital and monitored and treated for four hours. Then I was released.   At around 1:30 p.m. I felt my skin singling and started having difficulty breathing. Since I was no longer at my work (Hospital) I went to the closest hospital. This reaction was much worse. My husband drove. My heart rate increased.  I was released at around 6:30 pm
This case was considered medically important (OMIC). Information regarding Prevnar was received from a consumer regarding a 4 year old male patient who experienced autism. The patient received the third dose on 2/18/02. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on 12/18/02. Dose regimen was 1 dose (IM). Concomitant medications were not reported. A relative reported that her nephew, who was adopted, was diagnosed with autism in August 2005. She additionally noted that the child is in therapy for speech but not totally delayed. No additional information was available at the time of this report. See related case HQWYE337301NOV05 for reporter's son's SAE of autism.
Nausea, Headache, Stiff neck, Muscle pain at injection site, slight rash under left arm
Pt. rec'd. 5 yr. routine vaccines in office on 01-31-18. Seen again 02/02/18 for S/S = (LT) arm with redness/warmth; no induration; afebrile. Area 9 x 15 cm. Dx as local reaction to KINRIX. Tx - BENADRYL if achy. Monitor and C/B for fever/worsening.
No adverse event; temperature excursions have been administered to patient; temperature excursion that had occurred in a refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (temperature excursions have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion that had occurred in a refrigerator) and NO ADVERSE EVENT (No adverse event) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Sep-2022 at 2:11 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. In 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion that had occurred in a refrigerator). On 21-Sep-2022 at 2:11 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (temperature excursions have been administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (temperature excursions have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursion that had occurred in a refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown.         Vaccine 4th dose reported as 0.5 in Deltoid muscle. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022. The Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients. No information is available on that patient at this time.   Treatment drug was not reported.
pt returned to clinic 15JUL97 stated in AM 13JUL97 awoke w/gen hives, focial swelling & SOB;went to MD that day 13JUL97 rx DPH & steroid;discuss poss of allergy to tetanus;
Mother reports that child was playing in playground 3 hours after vaccine (mist) was given.  Child reported to have blood on face and arms.  After cleaning, found blood coming from nose.  Child did not report injury to nose.  Was not in pain.  Mother unsure how much child bled or for how long.  She relates that the bloody nose was from the Flu Mist.  Unsure whether dose was split between nostrils or given in one dose to one nostril.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 13-MAR-2013, the patient who was vaccinated with a first dose of PNEUMOVAX23 (lot  # H015749, expiry date 08-JUN-2014) 0.5 milliliter (ml), intramuscularly was inadvertently administered second dose of PNEUMOVAX23 (lot # H015749, expiry date 08-JUN-2014) on 21-MAR-2013. No adverse effect reported. Additional information is not expected.
Patient said that she went home after receiving the FLUZONE HD vaccine.  Between 5:45PM 12/4/16 and 2:00am 12/5/16, the patient said that she felt extremely cold, and "Blacked Out" for approximately 5 minutes, while in her bathroom.  She felt nauseated.  She said that her body temperature was 96.2F.
about a month after second dose, started feeling pain in area of injection like with the first dose. I though it was going to go away, but as of today I cannot do certain moves with my arm.  I feels almost like a tendon was touched or a nerve pinched and it feels like it shocks me every time I try to reach high or extending my arm to the back, front and cannot support the weight of my body if I lean on the left side when I'm working out.  I can't do my bed or lift any weight with that arm.
Initial report received on 18 April 2014 from an investigator participating in a trial. A male subject (age not reported), with no relevant medical history reported, had received an injection of ACAM2000 concomitantly with an injection of Typhoid Vaccine, Anthrax vaccine and PNEUMOVAX vaccine on 01 April 2014 (lot number, route and site of administration were not reported for the 4 vaccines). On 02 April 2014, the subject experienced a severe gun shot wound to the chest. He was hospitalized immediately after. He was treated with surgery and pain medication: NORCO tab per os every 4 to 6 hours. The subject was discharged from the hospital on 04 April 2014. He continued to take NORCO until 10 April 2014. The subject went to the doctor for a follow-up visit on 11 April 2014. He was prescribed and started taking PERCOCET tab every 4 to 6 hours, cyclobenzaprine tab per os TID and naproxen per os BID on 11 April 2014. At the time of the report, the subject was still being treated with these medications, and did not returned to work. He had residual effects still present. The subject's outcome is not recovered. According to the investigator, the event was not related to the study vaccine, and no action was taken. List of documents held by sender: none.
Patient was scheduled to receive their second COVID-19 booster dose. The patient was supposed to receive the bivalent formulation but was inadvertently administered the monovalent formulation. Patient waited in waiting room for 15 minutes without incident.
The patient was vaccinated inadvertently by staff who did not realize that the Moderna vaccine was not approved for those under 18.  She did not have any adverse effects at the time of vaccination or afterward. I spoke with her on the phone about an hour after the vaccination to explain the situation and she expressed understanding, and was advised to use V-Safe if any adverse effects should occur.
Deep muscle pain.  It hurts to lift anything and patient cant even shake his right arm. (ie...after washing hands, he can't shake water off his hand)Pain hurts from below shoulder to above inside of wrist.
Developed red area of induration, tenderness, pain and itching at site of vaccination on left arm. Area 2x3 in deg.
3/21/2021 Husband , reported that wife attended the Covid clinic 2/13/2021 and received #1 covid vaccine about 11:30 AM  Soon after she complained of Discomfort at site on right arm with area from shoulder to elbow swollen extremely tight, red, and had rash by evening.  Generalized side effects of nausea and weakness with the inability to ambulate unassisted.  She did have Covid #2 3/13/2021 with somewhat similar response but not as severe.
Drastic increase in arthritic pain in several joints that previously were never bothersome. This happened within 2-3 days of the shot. Increased levels of pain in multiple joints, specifically the groin and knees. My doctor believed this to be "reactive arthritis" that can be caused by a flu shot. He put me on new NSAIDs and prednisone which were ineffective. The pains in the groin and knee have lasted for over 7 months now and have shown no signs of lessening.
My daughter's second vaccine was given subcutaneously rather than in the muscle. I was not with her for the first vaccine, but I learned the same person administered it. I am concerned about two things:  1. Will my daughter develop the full immune response to the vaccine or will she be more vulnerable to COVID-19? 2. Is there a way to follow up with the pharmacy to ensure vaccines are being administered properly to others in the community?
Inflammation surrounds surface about 5.5 inches x 5.5 inches L deltoid where Menveo shot. Advised warm compress to affected area with Benadryl use as directed.
Headache, fatigue, nausea, shakiness, fever max 100, localized warmth and tenderness to left arm. Out of work for 2 days due to symptoms currently.
Approximately 10 minutes after vaccine administration patient had red flushing of face and chest, itching sensation of entire body. Vitals were normal, no angioedema, wheezing, shortness of breath, GI symptoms, or other signs of anaphylaxis. Given 50 mg of diphenhydramine and observed for 30 minutes, symptoms resolved, sent home with ED precautions. Referred to allergist/ immunologist after event for counseling on second dose
Pt developed chickenpox rash 10 days, post vax. Also, with fever. Mom states the rash is mild.
Weakness left side, loss of balance, some loss of sensation.  Ischemic Stroke -  MRI Impression 9/27/2022 - Acute infarct right thalamus measuring 11 mm in diameter. No evidence of mass effect or hemorrhage.
Patient claims to have experienced muscle pain (sore arm), arm swelling and redness, fever (102.5 -103 F), rash, shaking, atrophy, altered mental status, shortness of breath, nausea, vomiting, diarrhea, and altered taste.
Contacted Covid19.  High Temp, Sore Throat, Chills, Aches, General Not Feeling  Well, Sneezing (significant), Dry Cough, Headache
Immediately upon leaving the COVID shot parking lot at Hospital, I began to feel pain shooting down my arm all the way to my fingertips. Then I started to feel disoriented. Then, as I was driving myself home, I felt constriction in my chest, like I was barely holding onto consciousness, then pain shooting up my shoulder into the left side of my neck, the left side of my face, my left eye and into the left side of my head. My heart was pounding, my head was hurting intensely and I wondered whether I was having a stroke while trapped in stop and go traffic. The intense pain continued while I drove, for about 30 minutes. Then it subsided somewhat -- but continued through the evening. I could not get to The pain continued in my arm, up the left side of my body and into my head all night. I could not sleep. My heart was pounding. Somehow I dozed off around 2 or 3am. The next day I felt groggy and tired, with the more moderate pain continuing in my arm and all the way to my hand. Finally, on Monday morning, I was able to reach my doctor's office. I was told to go the ER, which I did. They could find nothing "emergent." The pain, tiredness and headaches continued through Thursday. Friday I started to feel better -- a week after the shot on Saturday, 2/27.
Information has been received from a health professional concerning an unspecified number of unspecified patients. No concurrent or historical conditions were reported. On unspecified dates since 01-NOV-2014, the patients were vaccinated with unspecified number of improperly stored doses of GARDASIL (dose, strength, lot # and route were not reported). No adverse effects were reported. This case was one of three cases received from the same reporter. Additional information has been requested.
Information has been received from a nurse practitioner concerning a currently 25 year old female patient who on unspecified dates was vaccinated with all 3 shots of GARDASIL (Lot # and route not reported). The nurse reported that after all 3 shots of GARDASIL the patient's hand opposite the shot was swelling and she had a headache and fever within 24 hours after the final shot. The patient did not seek medical attention. NO treatment was given. Subsequently, the patient was recovered in an unknown date. Follow up information has been received from nurse practitioner, initial reporter, concerning about 25 year old student patient with perennial allergies, none illness at the time of the report who at 13:37 on 13-MAR-2012 was vaccinated intramuscularly in left deltoid with a third dose of GARDASIL (dose not reported, Lot # 17226AA during verification process). On 14-MAR-2012 the patient experienced hand swelling - opposite hand from arm which shot was given. In about 24 hours the patient experienced also headache and fever. It was reported that the patient had the same reactions after 2 first doses of GARDASIL (dates, doses, route and Lot number not reported). It was reported that after the first dose of GARDASIL, the patient saw urgent care (not specified) and was given antibiotics (not specified). On the other had it was also reported that the patient had none adverse event following prior vaccination. The patient did not undergo any lab diagnostic test. At the time of the report the patient's status was recovered (recovery date was not reported - it was mentioned that patient recovered after 24 hours). No further information is expected.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 08Sep2021 04:30 (Batch/Lot number: unknown) at the age of 34 years as dose 2, single and administered in leg left, administration date 08Sep2021 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Multiple sclerosis" (unspecified if ongoing), notes: other medical history: Ms. There were no concomitant medications. The following information was reported: OVERDOSE (non-serious) with onset 08Sep2021, outcome "unknown", described as "Administration date: 08Sep2021, Dose number: 2, Administration date: 08Sep2021, Dose number:1"; PAIN (non-serious) with onset 08Sep2021 18:45, outcome "recovering", described as "body ache"; CHILLS (non-serious) with onset 08Sep2021 18:45, outcome "recovering", described as "shivers/chills". Therapeutic measures were not taken as a result of pain, chills. Additional information: Patient had not received other vaccine in four weeks. Patient not had Covid prior vaccination and was not tested to Covid post vaccination. Patient had no known allergies. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Initial report was received from a healthcare professional on 05 December 2012. This patient also experienced another adverse event which was captured in case number 2012-11686. A five-month-old female patient received a dose of PENTACEL and a dose of Rotavirus (lot numbers, routes and sites of administration not reported) on 07 November 2011 and an unspecified amount of time later experienced vomiting, fever and seizure like activity. The patient had no illness at the time of vaccination and no known allergies (NKA). The patient experienced fever and vomiting right after receiving PENTACEL, hepatitis B vaccine, Rotavirus vaccine and PNEUMOVAX (captured in case number 2012-11686). Outcome was unknown. Documents held by sender: None.
17 years of age patient inadvertently received 1st dose of the Moderna vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age patient inadvertently received 1st dose of the Moderna vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age patient inadvertently received 1st dose of the Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age patient inadvertently received 1st dose of the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.    This case was linked to MOD21-081105 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow up received on 27 May 2021; Sender's Comments:  MOD21-081105:Case for patient 2
Mild muscle and joint aches; Mild muscle and joint aches; This is a spontaneous report from a contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. Medical history included celiac disease. The patient did not have any allergies to food, medications, or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included unspecified birth control medication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 25Mar2021 at 14:00 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. On 16Apr2021 at 08:00, the patient experienced mild muscle and joint aches starting the morning after receiving the vaccine, which lasted until mid-day. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were taken as a result of events mild muscle and joint aches which included treatment with ibuprofen. The clinical outcome of the events mild muscle and joint aches was recovered on 16Apr2021, until mid-day.  No follow-up attempts are needed. No further information is expected.
Patient presents with small nodule on the lateral aspect of the outer right arm. Mild painful to the touch with no erythema. No treatment and nodule has faded since onset.
Tested Positive 8/8/2021 - Fever, Muscle aches, Runny nose, sore throat, Loss of Taste/smell, Headache fatigue, Nausea
Expired vaccine used; Product administration error; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Product administration error) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Product administration error). On 22-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Product administration error) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.